Chief Scientific Officer

Topiol_PictureSid Topiol received his B.S. from CCNY and his Ph.D. from NYU. He trained as a theoretical quantum chemist. He post-docked at Northwestern with Mark Ratner and Arthur Frost, and at Carnegie-Mellon with John Pople (Noble laureate.) He first joined The Mount Sinai School of Medicine in the Department of Pharmacology. He has spent over 20 years in Pharma, starting with Berlex followed by Sandoz/Novartis and then Lundbeck. He has worked on all aspects of Computer Aided Drug Design in interdisciplinary project environments. He now combines industry and academic activities. In 2010 he formed 3D-2Drug, a consulting company which provides the means for the most efficient discovery activities through advanced scientific approaches. In 2011 he began teaching as an Adjunct Lecturer at New Jersey Institute of Technology and has, in 2014, joined the newly forming Center for Healthcare Innovation at the Stevens Institute of Technology.